Pharmacokinetics of organic nitrates in man: an overview
- PMID: 3137070
- DOI: 10.1093/eurheartj/9.suppl_a.33
Pharmacokinetics of organic nitrates in man: an overview
Abstract
The pharmacokinetics of glyceryl trinitrate are still not completely understood. The substance disappears rapidly from plasma largely by extrahepatic mechanisms. It is converted in glyceryl dinitrates and glyceryl mononitrates. After transdermal application of a controlled delivery system, plasma concentrations of glyceryl trinitrate can be maintained over the time period of application but, as for other routes, there are important intra- and inter-individual variations and fluctuations. Isosorbide dinitrate disappears less rapidly from the body; it is converted to the isosorbide mononitrates. Plasma concentrations of isosorbide dinitrate and mononitrates are quite predictable in different circumstances, e.g. on application of oral sustained release formulations. Measurement of the plasma concentrations of nitrates has been used to characterize different preparations and routes of administration. However, these plasma concentrations cannot be used to predict the effect, probably because of the important counter-regulation and tolerance which develop rapidly after administration of the drugs.
Similar articles
-
Clinical pharmacokinetics of nitrates.Cardiovasc Drugs Ther. 1994 Oct;8(5):693-9. doi: 10.1007/BF00877116. Cardiovasc Drugs Ther. 1994. PMID: 7873466 Review.
-
Relationship of pharmacokinetic and pharmacodynamic properties of the organic nitrates.Clin Pharmacokinet. 1988 Jul;15(1):32-43. doi: 10.2165/00003088-198815010-00003. Clin Pharmacokinet. 1988. PMID: 3135973 Review.
-
Clinical pharmacokinetics of organic nitrates.Clin Pharmacokinet. 1983 Sep-Oct;8(5):410-21. doi: 10.2165/00003088-198308050-00003. Clin Pharmacokinet. 1983. PMID: 6414751 Review.
-
The pattern of glyceryl nitrates after oral administration of glyceryl trinitrate.Arzneimittelforschung. 1988 Jan;38(1):103-5. Arzneimittelforschung. 1988. PMID: 3130064
-
[Concentration-time profile of isosorbide dinitrate and its metabolites in plasma following percutaneous resorption of a transdermal therapeutic system].Arzneimittelforschung. 1987 Nov;37(11):1301-3. Arzneimittelforschung. 1987. PMID: 3440041 German.
Cited by
-
Clinical pharmacokinetics of vasodilators. Part II.Clin Pharmacokinet. 1998 Jul;35(1):9-36. doi: 10.2165/00003088-199835010-00002. Clin Pharmacokinet. 1998. PMID: 9673832 Review.
-
The effects of organic nitrates on osteoporosis: a randomized controlled trial [ISRCTN94484747].Trials. 2006 Apr 26;7:10. doi: 10.1186/1745-6215-7-10. Trials. 2006. PMID: 16640783 Free PMC article.
-
Microvascular retinopathy and angiographically-demonstrated coronary artery disease: A cross-sectional, observational study.PLoS One. 2018 May 8;13(5):e0192350. doi: 10.1371/journal.pone.0192350. eCollection 2018. PLoS One. 2018. PMID: 29738542 Free PMC article.
-
Nitrates and bone turnover (NABT) - trial to select the best nitrate preparation: study protocol for a randomized controlled trial.Trials. 2013 Sep 8;14:284. doi: 10.1186/1745-6215-14-284. Trials. 2013. PMID: 24010992 Free PMC article. Clinical Trial.
-
EPR-Effect Enhancers Strongly Potentiate Tumor-Targeted Delivery of Nanomedicines to Advanced Cancers: Further Extension to Enhancement of the Therapeutic Effect.J Pers Med. 2021 May 28;11(6):487. doi: 10.3390/jpm11060487. J Pers Med. 2021. PMID: 34071552 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources